|
Featured Stories
|
|
|
|
Thursday, 04 Mar 2010
Lombard’s device has been utilised in the largest series of patients with difficult and tortuous anatomy ever studied and had outstanding clinical results. [more]
|

|
|
Monday, 01 Mar 2010
The eagerly awaited results of the CREST (Carotid revascularisation endarterectomy versus stenting) trial were announced on Friday 26 February at the American Stroke Association International Stroke Conference 2010. Both procedures were shown to be equally safe and effective for the treatment of carotid atherosclerosis and the prevention of stroke, myocardial infarction, and death. [more]
|

|
|
Thursday, 25 Feb 2010
Current trends in vascular imaging were presented on 22 January 2010 at the Controverses et Actualités en Chirurgie Vascularie (CACVS) meeting in Paris, France. [more]
|

|
|
Thursday, 04 Feb 2010
Experts say that while drug-eluting balloon technology is showing promising signs, it is too early to claim that this is the next big landmark in endovascular therapy. [more]
|

|
|
Thursday, 04 Feb 2010
In recent years, the implantation of covered stents has emerged as a strategy for the treatment of occlusions in the superficial femoral artery. In several smaller studies, covered stenting of the superficial femoral artery has shown superior patency at two years after intervention. [more]
|

|
|
Thursday, 04 Feb 2010
New devices for debulking chronic occlusions emerge every year. To date, no single device is able to achieve the removal of the occlusion material in its entirety, as further angioplasty is usually needed. However, there are some devices on the horizon that show promise in moving towards a solution for heavily calcified lesions. [more]
|

|
|
Thursday, 04 Feb 2010
Medtronic’s acquisition of Invatec will enable the company to arm its peripheral vascular product range and obtain four drug-eluting balloons, currently being hailed as one of the most promising interventional devices. [more]
|

|
|
Tuesday, 19 Jan 2010
Study presented at the ISET 2010 compared the results of 25 patients who underwent EVAR to 33 who underwent open surgery. [more]
|

|
|
Tuesday, 19 Jan 2010
A new type of EVAR device that treats the entire aneurysm – a bag instead of a tube – could solve some of the problems of endografts, including leaking and shifting of the device. [more]
|

|
|
Monday, 18 Jan 2010
CELLO study demonstrated significant reduction in artery blockage following excimer laser ablation with Turbo-Booster with no major adverse events. [more]
|

|
|
Tuesday, 12 Jan 2010
Preliminary results at six-month follow-up, presented by Marc Bosiers at the VEITHsymposium showed that drug-eluting stents had a higher primary patency rate in below-the-knee critical limb ischaemia lesions in comparison with bare metal stents [more]
|

|
|
Tuesday, 12 Jan 2010
Thomas A Sos, a well-known interventional radiologist from New York-Presbyterian Hospital, Weill-Cornell, New York, USA, critiqued the STAR and ASTRAL trials at the recently held VEITHsymposium, in New York. [more]
|

|
|
Friday, 15 Jan 2010
The question of how to treat asymptomatic carotid stenosis patients took centre stage at the VEITHsymposium, in New York, USA, in November 2009. [more]
|

|
|
Monday, 11 Jan 2010
Researchers in Sweden reviewed the data of 172,890 twins born in that country since 1886 and found 265 twins who had developed abdominal aortic aneurysms. [more]
|

|
|
Wednesday, 06 Jan 2010
Bone marrow stem cell autologous transplant could become a promising new frontier in the hand of vascular specialists for the treatment of peripheral artery occlusive disease. [more]
|

|
|
Friday, 04 Dec 2009
New scoring system provides criteria to quantify perioperative risks in Medicare patients, shows study published in the Journal of Vascular Surgery. [more]
|

|
|
Thursday, 03 Dec 2009
The findings of study conducted by researchers at Beth Israel Deaconess Medical Center, Boston, USA, demonstrate that a protein called PGC-1alpha plays a key role in the process. [more]
|

|
|
Friday, 27 Nov 2009
Global partnership with Vital Images leverages advanced visualisation technology to streamline pre-case planning through patient follow-up. [more]
|

|
|
Tuesday, 10 Nov 2009
The device is available in an expanded portfolio of sizes to meet a broad range of patient needs and was engineered to treat multiple etiologies. [more]
|

|
|
Thursday, 05 Nov 2009
None of the statin patients in the study died after the aneurysm repair procedure, whereas 5% of those not taking statins died after the operation. [more]
|

|
|
|